| Abigail C Straight, SLP | |
|
16120 Ne 8th St, Bellevue, WA 98008-3937 | |
| (425) 747-4004 | |
| (425) 747-1069 |
| Full Name | Abigail C Straight |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 16120 Ne 8th St, Bellevue, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114639846 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL6134196 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Abigail C Straight, SLP 16120 Ne 8th St, Bellevue, WA 98008-3937 Ph: (425) 747-4004 | Abigail C Straight, SLP 16120 Ne 8th St, Bellevue, WA 98008-3937 Ph: (425) 747-4004 |
News Archive
Multidrug-resistant TB (MDR-TB) is the disease caused by TB bacilli that are resistant to at least isoniazid and rifampicin – the two most powerful anti-TB drugs. It results from inconsistent or partial treatment of TB, and develops when public health programmes fail to deliver regular and reliable treatment to TB patients.
While it has become clear in recent years that susceptibility to pain has a strong inherited component, very little is known about actual "pain genes" and how they work. In the November 12th issue of Cell, researchers at Children's Hospital Boston and their collaborators report on a novel human pain gene. People with minor variations in this gene showed clear differences in susceptibility to acute heat pain and chronic back pain.
The U.S. Food and Drug Administration today approved Provenge (sipuleucel-T), a new therapy for certain men with advanced prostate cancer that uses their own immune system to fight the disease.
The Institute of Medicine supplemented its earlier list of ideas for overhauling the system of geographic adjustments to Medicare payments with four more suggestions today.
Regado Biosciences, Inc, a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents, today announced enrollment of the first patient in the first Phase I study of a subcutaneous administration formulation of the REG1 anticoagulation system.
› Verified 5 days ago
Alexandra Marie Gomez, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1417 116th Ave Ne, Suite 110, Bellevue, WA 98004 Phone: 425-688-5900 Fax: 425-688-5912 | |
Elise Morrison, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5150 Village Park Dr Se, Bellevue, WA 98006 Phone: 425-657-0620 Fax: 425-502-8425 | |
Andrea Nicole Jamieson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16120 Ne 8th St, Bellevue, WA 98008 Phone: 425-747-4004 Fax: 425-747-1069 | |
Mrs. Katherine Jeanne Oberhofer, MS CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1417 116th Ave Ne Ste 110, Bellevue, WA 98004 Phone: 425-688-5911 Fax: 425-688-5912 | |
Mrs. Lori Anne Price, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12 Lummi Key, Bellevue, WA 98006 Phone: 425-643-2919 Fax: 425-657-0691 | |
Mackenzie Bush, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13333 Ne Bel Red Rd Ste 100, Bellevue, WA 98005 Phone: 501-352-0101 | |
Genenvieve Decantis, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5150 Village Park Dr Se, Bellevue, WA 98006 Phone: 425-657-0620 |